Bhatia Sangeeta N.
SEC Form 4 insider trading activity
Bhatia Sangeeta N. has filed 3 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 5, 2026.
On the most recent filing, Bhatia Sangeeta N. is listed as Director at VERTEX PHARMACEUTICALS INC / MA. Inside the rolling window, Bhatia Sangeeta N. reported no open-market purchases and 2 open-market sales totaling $268K in VRTX. The largest disclosed transaction in the window is a sale of 318 VRTX shares on May 4, 2026, worth $135K.
Companies traded
Other insiders at VRTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$268K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 27, 2025 | VRTX | Sale | $103K |
Frequently asked questions
How many SEC Form 4 filings has Bhatia Sangeeta N. made?
Bhatia Sangeeta N. has filed 3 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.
Which companies does Bhatia Sangeeta N. trade?
Bhatia Sangeeta N. has filed SEC Form 4 disclosures for 1 company, including VRTX.
When was Bhatia Sangeeta N.'s most recent SEC Form 4 filing?
Bhatia Sangeeta N.'s most recent SEC Form 4 filing on Tracefour is dated May 5, 2026.
What is Bhatia Sangeeta N.'s total buy and sell value in the current window?
Inside the rolling retention window, Bhatia Sangeeta N. bought $0 and sold $268K based on SEC Form 4 filings.
What was Bhatia Sangeeta N.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 318 VRTX shares on 2026-05-04, worth $135K, per SEC Form 4 filings.